Healthpeak Properties, Inc. · DOC · Next earnings

Healthpeak Properties, Inc. reports Thursday, Oct 22, 2026

DOC reports after market close with consensus EPS at $0.05 and revenue at $743.4M. Last quarter: Healthpeak Q1: Raised FFO Guidance, Janus Living IPO, $100M Buyback Mark Pivot to Growth

Reports After market close32 days awayDate estimated Real Estate

What the street expects

Consensus for the coming report
Consensus EPS $0.05 Calendar consensus
Consensus revenue $743.4M Calendar consensus
Report date Oct 22, 2026 Thursday, date estimated
Session After market close 32 days away

Where DOC left off: FY2026 Q1

Full report

Healthpeak Q1: Raised FFO Guidance, Janus Living IPO, $100M Buyback Mark Pivot to Growth

EPS surprise +430.7% Reported $0.28 vs $0.05
Revenue surprise +6.4% Reported $738.8M vs $694.6M
Stock move +18.1% Event window
Subsequent drift +0.5% Up to 20 sessions

Raised. Adjusted FFO guidance lifted to $1.71-$1.75 per share from a previously maintained posture. Same-store NOI guidance remains flat. The Janus Living IPO is expected to be earnings-neutral in 2026 and accretive in 2027.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Higher interest expense ($20M) and increased G&A ($5M) could compress earnings.
  • $650M senior notes refinancing in June adds near-term refinancing risk.
  • Potential slowdown in lab leasing spreads if vacancy persists or market rents soften.
  • Execution risk around large acquisitions and joint-venture recaps.
  • Occupancy trajectory and potential move-outs in 2027 could pressure lab segment.

Questions analysts left open

  • Timing and scale of opportunistic life-science investments.
  • Impact of the Janus Living IPO on earnings and cash flow.
  • Future lease economics and re-leasing spreads for labs.
  • Occupancy trajectory and potential move-outs in 2027.

Ask FN2 about DOC next report

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the DOC recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent DOC quarters

All DOC earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q1

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.